UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Disease-Drug-Drug Interaction Involving Tocilizumab and Simvastatin in Patients With Rheumatoid Arthritis

Clinical pharmacology and therapeutics, 2011-05, Vol.89 (5), p.735-740

2011

Volltextzugriff (PDF)

Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial

Annals of the rheumatic diseases, 2009-06, Vol.68 (6), p.922-929

2009

Volltextzugriff (PDF)

Intraarticular injection of anakinra in osteoarthritis of the knee: A multicenter, randomized, double‐blind, placebo‐controlled study

Arthritis and rheumatism, 2009-03, Vol.61 (3), p.344-352

2009

Volltextzugriff (PDF)

Denosumab improves density and strength parameters as measured by QCT of the radius in postmenopausal women with low bone mineral density

Bone (New York, N.Y.), 2010-07, Vol.47 (1), p.131-139

2010

Volltextzugriff (PDF)

Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis

Annals of the rheumatic diseases, 2008-03, Vol.67 (3), p.346-352

2008

Volltextzugriff (PDF)

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial

JAMA : the journal of the American Medical Association, 1999-11, Vol.282 (20), p.1921

1999

Volltextzugriff (PDF)

Synovial and systemic pharmacokinetics (PK) of triamcinolone acetonide (TA) following intra-articular (IA) injection of an extended-release microsphere-based formulation (FX006) or standard crystalline suspension in patients with knee osteoarthritis (OA)

Osteoarthritis and cartilage, 2018-01, Vol.26 (1), p.34-42

2018

Volltextzugriff (PDF)

A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study

Osteoarthritis and cartilage, 2017-10, Vol.25 (10), p.1598-1606

2017

Volltextzugriff (PDF)

A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis

Annals of the rheumatic diseases, 2005-01, Vol.64 (1), p.64-69

2005

Volltextzugriff (PDF)

Peficitinib, a JAK Inhibitor, in the Treatment of Moderate‐to‐Severe Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate

Arthritis & rheumatology (Hoboken, N.J.), 2017-04, Vol.69 (4), p.709-719

2017

Volltextzugriff (PDF)

CGRP blockade by galcanezumab was not associated with reductions in signs and symptoms of knee osteoarthritis in a randomized clinical trial

Osteoarthritis and cartilage, 2018-12, Vol.26 (12), p.1609-1618

2018

Volltextzugriff (PDF)

Reduced incidence of gastroduodenal ulcers associated with lumiracoxib compared with ibuprofen in patients with rheumatoid arthritis

Alimentary pharmacology & therapeutics, 2004-06, Vol.19 (11), p.1189-1198

2004

Volltextzugriff (PDF)

Safety, pharmacokinetics, and pharmacodynamics of RSLV-132, an RNase-Fc fusion protein in systemic lupus erythematosus: a randomized, double-blind, placebo-controlled study

Lupus, 2017-07, Vol.26 (8), p.825-834

2017

Volltextzugriff (PDF)

A comparison of the upper gastrointestinal mucosal effects of valdecoxib, naproxen and placebo in healthy elderly subjects

Alimentary pharmacology & therapeutics, 2003-07, Vol.18 (1), p.125-132

2003

Volltextzugriff (PDF)

Comparative Efficacy and Safety of Celecoxib and Naproxen in the Treatment of Osteoarthritis of the Hip

Journal of international medical research, 2001-12, Vol.29 (6), p.467-479

2001

Volltextzugriff (PDF)

A walking model to assess the onset of analgesia in osteoarthritis knee pain

Osteoarthritis and cartilage, 2010-05, Vol.18 (5), p.646-653

2010

Volltextzugriff (PDF)

THU0239 Methotrexate Dose has Minimal Effects on Methotrexate-Related Toxicity in Patients with Early Rheumatoid Arthritis Treated in Combination with Adalimumab – Results of Concerto Trial

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A246-A246

2013

Volltextzugriff (PDF)

Comparison of the upper gastrointestinal safety of arthrotec ® 75 and nabumetone in osteoarthritis patients at high risk for developing nonsteroidal anti-inflammatory drug-induced gastrointestinal ulcers

Clinical therapeutics, 1999-04, Vol.21 (4), p.659-674

1999

Volltextzugriff (PDF)

Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain

Pain (Amsterdam), 2013-07, Vol.154 (7), p.1009-1021

2013

Volltextzugriff (PDF)

Denosumab in Postmenopausal Women with Low Bone Mineral Density

The New England journal of medicine, 2006-02, Vol.354 (8), p.821-831

2006

Volltextzugriff (PDF)

Pain management in osteoarthritis: A focus on onset of efficacy—a comparison of rofecoxib, celecoxib, acetaminophen, and nabumetone across four clinical trials

The journal of pain, 2004-11, Vol.5 (9), p.511-520

2004

Volltextzugriff (PDF)

A placebo-controlled, randomized, double-blinded study evaluating the safety of etanercept in patients with rheumatoid arthritis and concomitant comorbid diseases

Rheumatology (Oxford, England), 2007-07, Vol.46 (7), p.1122-1125

2007

Volltextzugriff (PDF)

Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept

Journal of rheumatology, 2006-04, Vol.33 (4), p.712

2006

Volltextzugriff (PDF)

A comparison of valdecoxib and naproxen in the treatment of rheumatoid arthritis symptoms

Clinical therapeutics, 2006-02, Vol.28 (2), p.204-221

2006

Volltextzugriff (PDF)

Efficacy and Safety of Rofecoxib 12.5 mg Versus Nabumetone 1,000 mg in Patients with Osteoarthritis of the Knee: A Randomized Controlled Trial

Journal of the American Geriatrics Society (JAGS), 2004-05, Vol.52 (5), p.666-674

2004

Volltextzugriff (PDF)

1 – 25 von 287

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(261)
Mit Volltextzugriff
(226)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(169)
Life Sciences & Biomedicine
(165)
Humans
(130)
Rheumatology
(116)
Female
(108)
Middle Aged
(105)
Male
(94)
Double-Blind Method
(89)
Adult
(83)
Treatment Outcome
(73)
Aged
(68)
Biological And Medical Sciences
(57)
Medical Sciences
(55)
Rheumatoid Arthritis
(42)
Arthritis
(37)
Arthritis, Rheumatoid - Drug Therapy
(36)
Diseases Of The Osteoarticular System
(36)
Patients
(35)
Antirheumatic Agents - Therapeutic Use
(34)
Pharmacology. Drug Treatments
(34)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Disease-Drug-Drug Interaction Involving Tocilizumab and Simvastatin in Patients With Rheumatoid Arthritis

Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial

Intraarticular injection of anakinra in osteoarthritis of the knee: A multicenter, randomized, double‐blind, placebo‐controlled study

Denosumab improves density and strength parameters as measured by QCT of the radius in postmenopausal women with low bone mineral density

Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial

Synovial and systemic pharmacokinetics (PK) of triamcinolone acetonide (TA) following intra-articular (IA) injection of an extended-release microsphere-based formulation (FX006) or standard crystalline suspension in patients with knee osteoarthritis (OA)

A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study

A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis

Peficitinib, a JAK Inhibitor, in the Treatment of Moderate‐to‐Severe Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate

CGRP blockade by galcanezumab was not associated with reductions in signs and symptoms of knee osteoarthritis in a randomized clinical trial

Reduced incidence of gastroduodenal ulcers associated with lumiracoxib compared with ibuprofen in patients with rheumatoid arthritis

Safety, pharmacokinetics, and pharmacodynamics of RSLV-132, an RNase-Fc fusion protein in systemic lupus erythematosus: a randomized, double-blind, placebo-controlled study

A comparison of the upper gastrointestinal mucosal effects of valdecoxib, naproxen and placebo in healthy elderly subjects

Comparative Efficacy and Safety of Celecoxib and Naproxen in the Treatment of Osteoarthritis of the Hip

A walking model to assess the onset of analgesia in osteoarthritis knee pain

THU0239 Methotrexate Dose has Minimal Effects on Methotrexate-Related Toxicity in Patients with Early Rheumatoid Arthritis Treated in Combination with Adalimumab – Results of Concerto Trial

Comparison of the upper gastrointestinal safety of arthrotec ® 75 and nabumetone in osteoarthritis patients at high risk for developing nonsteroidal anti-inflammatory drug-induced gastrointestinal ulcers

Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain

Denosumab in Postmenopausal Women with Low Bone Mineral Density

Pain management in osteoarthritis: A focus on onset of efficacy—a comparison of rofecoxib, celecoxib, acetaminophen, and nabumetone across four clinical trials

A placebo-controlled, randomized, double-blinded study evaluating the safety of etanercept in patients with rheumatoid arthritis and concomitant comorbid diseases

Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept

A comparison of valdecoxib and naproxen in the treatment of rheumatoid arthritis symptoms

Efficacy and Safety of Rofecoxib 12.5 mg Versus Nabumetone 1,000 mg in Patients with Osteoarthritis of the Knee: A Randomized Controlled Trial

Suchergebnisse filtern